1 | Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIV | 2ᵒ autor: Caro-Vega Y., Núñez I., MacDonald C., Mosqueda J.L., et al. | 2025 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | WoS-id: 001439269400001 Scopus-id: 2-s2.0-85215854304
| 0 | 0 |
2 | Challenges to the HIV Care Continuum During the COVID-19 Pandemic in Mexico: A Mixed Methods Study | Coautor: Caro-Vega Y., Núñez I., Amuchastegui A., Vásquez-Salinas A., et al. | 2024 | AIDS AND BEHAVIOR | WoS-id: 001074441700001 Scopus-id: 2-s2.0-85173120453
| 4 | 4 |
3 | Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed | 2ᵒ autor: Caro-Vega, Y, Núñez, I, MacDonald, C, Mosqueda-Gómez, JL, et al. | 2024 | Open Forum Infectious Diseases | WoS-id: 001296767400003 Scopus-id: 2-s2.0-85202026993
| 2 | 2 |
4 | Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico | Coautor: Caro-Vega, Yanink, Belaunzaran-Zamudio, Pablo F., Naranjo, Lizbeth, Castillo-Mancilla, Jose R., et al. | 2023 | AIDS RESEARCH AND HUMAN RETROVIRUSES | WoS-id: 000936658100001 Scopus-id: 2-s2.0-85150000405
| 2 | 2 |
5 | Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational Study | Coautor: Vega Y.C., Romo M.L., Patel R.C., Edwards J.K., et al. | 2022 | ANNALS OF INTERNAL MEDICINE | WoS-id: 000729195600001 Scopus-id: 2-s2.0-85123814148
| 19 | 19 |
6 | Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and Colombia | Coautor y autor de correspondencia: Caro-Vega Y., Núñez I., Belaunzarán-Zamudio P.F. | 2022 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000751326000001 Scopus-id: 2-s2.0-85128160140
| 9 | 10 |
7 | Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capital | 2ᵒ autor: Caro-Vega Y., Núñez I., Belaunzarán-Zamudio P.F. | 2022 | Public Health | WoS-id: 000784028900029 Scopus-id: 2-s2.0-85126528318
| 6 | 7 |
8 | Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City | Coautor: Caro-Vega Y.N., Dávila-Conn V., Soto-Nava M., Paz-Juárez H.E., et al. | 2022 | PLOS ONE | WoS-id: 000784193600035 Scopus-id: 2-s2.0-85126685344
| 4 | 5 |
9 | Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial | Coautor: Caro-Vega, Yanink, Fragoso-Saavedra, Sergio, Núñez I., Audelo-Cruz, Belem M., et al. | 2022 | MOLECULAR MEDICINE | WoS-id: 000880335300002 Scopus-id: 2-s2.0-85141555280
| 7 | 7 |
10 | Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study | 1ᵉʳ autor: Caro-Vega Y., Rebeiro P.F., Shepherd B.E., Belaunzarán-Zamudio P.F., et al. | 2022 | LANCET REGIONAL HEALTH-AMERICAS | WoS-id: 000904623700012 Scopus-id: 2-s2.0-85126975031
| 2 | 2 |
11 | Characterizing Groups Using Latent Class Mixed Models: Antiretroviral Treatment Adherence Analysis | Coautor y autor de correspondencia: Caro-Vega Y., Fuentes-García R., Naranjo L. | 2022 | Springer Proceedings in Mathematics & Statistics | Scopus-id: 2-s2.0-85144444610
| 0 | 0 |
12 | Comparison of kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: A multiregional multicohort study | Coautor: Vega Y.C., Rohner E., Bütikofer L., Schmidlin K., et al. | 2017 | CLINICAL INFECTIOUS DISEASES | WoS-id: 000412022500009 Scopus-id: 2-s2.0-85032789580
| 39 | 46 |
13 | Monitoring of HIV treatment in seven countries in the WHO region of the Americas | 2ᵒ autor: Caro-Vega Y.N., Belaunzarán-Zamudio P.F., Shepherd B.E., Crabtree-Ramírez B.E., et al. | 2015 | BULLETIN OF THE WORLD HEALTH ORGANIZATION | WoS-id: 000359966400010 Scopus-id: 2-s2.0-84938538216
| 16 | 19 |
14 | CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean | Coautor: Caro-Vega Y., Luz P.M., Belaunzarán-Zamudio P.F., Crabtree-Ramírez B., et al. | 2015 | Open Forum Infectious Diseases | WoS-id: 000365786200030 Scopus-id: 2-s2.0-84978328152
| 7 | 7 |
15 | High prevalence of late diagnosis of HIV in Mexico during the HAART era | 2ᵒ autor: Caro-Vega Y., Crabtree-Ramírez B., Belaunzarán-Zamudio F., Sierra-Madero J. | 2012 | SALUD PUBLICA DE MEXICO | WoS-id: 000309320100009 Scopus-id: 2-s2.0-84867827846
| 29 | 30 |